Event organised by Terrapinn. The Congress, which is the largest rare disease event globally, will gather over 2,000 attendees. Covering the full orphan drug value chain, from cell and gene therapy, genetic testing, market access and real-world evidence, the conference brings together science, government and industry to drive progress.
Amsterdam
Ask for a Free trial and get access to the latest stories
Our coverage includes:
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
REQUEST
an initial 10 day temporary access of APM Market Access.
